![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © The Physiological Society 2003 Long-chain acyl-CoA esters and phosphatidylinositol phosphates modulate ATP inhibition of Katp channels by the same mechanism Institute of Physiology II, Friedrich Schiller University Jena, Teichgraben 8, 07740 Jena, Germany Corresponding author T. Baukrowitz: Institute of Physiology II, Friedrich Schiller University Jena, Teichgraben 8, 07740 Jena, Germany. Email: thbau/at/mti-n.uni-jena.de Author's present address T. Krauter: Flyion GmbH, Waldhäuserstrasse 34, 72076 Tübingen, Germany. Received May 13, 2003; Accepted August 1, 2003. This article has been cited by other articles in PMC.Abstract Phosphatidylinositol phosphates (PIPs, e.g. PIP2) and long-chain acyl-CoA esters (e.g. oleoyl-CoA) are potent activators of Katp channels that are thought to link Katp channel activity to the cellular metabolism of PIPs and fatty acids. Here we show that the two types of lipid act by the same mechanism: oleoyl-CoA potently reduced the ATP sensitivity of cardiac (Kir6.2/SUR2A) and pancreatic (Kir6.2/SUR1) Katp channels in a way very similar to PIP2. Mutations (R54Q, R176A) in the C- and N-terminus of Kir6.2 that greatly reduced the PIP2 modulation of ATP sensitivity likewise reduced the modulation by oleoyl-CoA, indicating that the two lipids interact with the same site. Polyvalent cations reduced the effect of oleoyl-CoA and PIP2 on the ATP sensitivity with similar potency suggesting that electrostatic interactions are of similar importance. However, experiments with differently charged inhibitory adenosine phosphates (ATP4-, ADP3- and 2′(3′)-O-(2,4,6-trinitrophenyl)adenosine 5′-monophosphate (TNP-AMP2-)) and diadenosine tetraphosphate (Ap4A5-) ruled out a mechanism where oleoyl-CoA or PIP2 attenuate ATP inhibition by reducing ATP binding through electrostatic repulsion. Surprisingly, CoA (the head group of oleoyl-CoA) did not activate but inhibited Katp channels (IC50 = 265 ± 33 μM). We provide evidence that CoA and diadenosine polyphosphates (e.g. Ap4A) are ligands of the inhibitory ATP-binding site on Kir6.2. KATP channels are hetero-octameric protein complexes, formed by the association of four inwardly rectifying potassium channel subunits (Kir6.2) and four regulatory sulphonylurea receptor subunits (SUR1 or SUR2). They serve as metabolic sensors in many tissues by linking cellular metabolism to membrane excitability. This function arises from their ability to respond to changes in the intracellular concentrations of ATP and ADP. Intracellular ATP binds to a site on Kir6.2 and inhibits KATP channel activity. MgADP interacts with the SUR and activates KATP channels by antagonizing the inhibitory effect of ATP (Nichols & Lopatin, 1997). In addition, recent work has uncovered two distinct classes of lipids as potent activators of KATP channels: long-chain acyl-coenzyme A (LC-CoA) esters (Branstrom et al. 1998; Gribble et al. 1998; Liu et al. 2001) and phosphatidylinositol phosphates (PIPs) (Fan & Makielski, 1997; Baukrowitz et al. 1998; Shyng & Nichols, 1998). Both types of lipid have been shown to increase the open probability and to reduce the ATP sensitivity of KATP channels. The effect on ATP sensitivity is of particular physiological importance since the amount of ATP inhibition determines the activity of KATP channels in cells. LC-CoA esters represent the metabolizable form of LC-fatty acids, which fuel β-oxidation in the mitochondria. Elevated levels of LC-CoA esters have been reported for different pathophysiological situations (ischaemic heart, diabetes mellitus, obesity) in tissues that strongly express KATP channels, pointing to a physiological or pathophysiological relevance for the regulation of KATP channels by LC-CoA esters (van der Vusse et al. 1992; Larsson et al. 1996; Gribble et al. 1998; Deeney et al. 2000; Liu et al. 2001). For instance, it has been suggested that activation of KATP channels by LC-CoA esters may contribute to the development of glucose insensitivity in pancreatic β cells (Larsson et al. 1996). PIPs represent a mechanism to regulate KATP channels by various receptors linked to the metabolism of PIPs (e.g. PLC, PI-kinases) (Baukrowitz & Fakler, 2000). In addition, not only are PIPs essential for the functioning of KATP channels but also all members of the Kir channel family are thought to interact with PIPs (especially PIP2) (Rohacs et al. 2003). Furthermore, mutations in Kir channels that disrupt these interactions with PIPs can lead to channelopathies such as Andersen's and Bartter's syndromes (Lopes et al. 2002). In contrast, LC-CoA esters appear to be specific modulators of KATP channels since none of the other Kir channels (Kir1.1, Kir2.1, Kir3.4, Kir4.1, Kir7.1) tested so far was activated by LC-CoA esters (Rohacs et al. 2003). Several basic residues in the N-terminus (e.g. R54) (Cukras et al. 2002; Schulze et al. 2003) and C-terminus (e.g. R176, R177, R192, R206, R301, R314) (Fan & Makielski, 1997; Shyng et al. 2000) of Kir6.2 have been implicated in the binding of PIP2. Mutations at these positions resulted in KATP channels with a low open probability that could be restored to normal upon application of PIP2, consistent with a reduced PIP2 affinity. In addition, mutations of R176 and, in particular, R54 have been shown to reduce the modulation of ATP inhibition by PIP2 (Baukrowitz et al. 1998; Schulze et al. 2003). The interactions of PIP2 with the implicated residues are thought to be mainly electrostatic, e.g. substitutions at position 54 reduce the effect of PIP2 on ATP inhibition in the order R54E > R54Q >R54K = wild-type (WT; Schulze et al. 2003). Further, polyvalent cations (e.g. polylysine, Mg2+, Ca2+), which are thought to bind to the negatively charged PIPs, abolish the effects of PIPs on KATP channels (Fan & Makielski, 1997; Shyng & Nichols, 1998; Krauter et al. 2001). LC-CoA esters are also thought to interact with the Kir6.2 subunits (Branstrom et al. 1998; Gribble et al. 1998), but the involvement of specific residues in the modulation by LC-CoA esters has not been demonstrated. Two mechanisms have been put forward to account for the reduction of ATP inhibition by PIPs. Firstly, PIPs and ATP control the open probability of KATP channels by an allosteric mechanism, with PIPs stabilizing the open state and ATP stabilizing the closed state of the channel (Enkvetchakul et al. 2000). In addition, it has been suggested that PIPs and ATP bind to overlapping (neighbouring) sites on the channel and compete directly for binding (Fan & Makielski, 1999; MacGregor et al. 2002). Given that PIPs and ATP are highly negatively charged molecules, this competition might involve electrostatic repulsion (Deutsch et al. 1994; Fan & Makielski, 1999). Previous studies have indicated differences in the activation of KATP channels by LC-CoA esters and PIPs. In contrast to PIP2, LC-CoA appeared to reduce the ATP sensitivity of cardiac KATP channels (Liu et al. 2001) more potently compared with pancreatic KATP channels (Gribble et al. 1998). Further, the effects of LC-CoA esters on KATP channels were reported to be insensitive to Ca2+ indicating that electrostatic interactions are less critical for the effect of LC-CoA esters compared with PIP2 (Liu et al. 2001). These results might indicate mechanistic differences for the effects of PIPs and LC-CoA esters on KATP channels. To resolve this issue we evaluated the modulation of KATP channels by oleoyl-CoA and PIP2 by testing cardiac and pancreatic KATP channels, different inhibitory (di)adenosine phosphates (Ap4A, ATP, ADP, AMP), polyvalent cations (polylysine, Mg2+) and mutations that are thought to reduce PIP2 sensitivity. METHODS The experiments were carried out with the approval of the local animal care committee Thueringer Landesamt für Lebensmittelsicherheit und Verbraucherschutz. Mutagenesis, cRNA synthesis and oocyte injection Murine Kir6.2, rat SUR2A and murine SUR1 were kindly provided by Dr F. M. Ashcroft. Site-directed mutagenesis was performed as described previously (Baukrowitz et al. 1999) and verified by sequencing. For oocyte expression, constructs were subcloned into the pBF expression vector (Fakler et al. 1995). Capped cRNAs were synthesized in vitro using SP6 polymerase (Promega, Heidelberg, Germany) and stored in stock solutions at -70 °C. Xenopus oocytes were surgically removed from adult females under anaesthesia (0.4% 3-aminobenzoic acid ethyl ester) and manually dissected. Frogs were humanely killed after the final oocyte collection. About 50 nl of a solution containing cRNA specific for SUR2A, SUR1 and Kir6.2 subunits was injected into Dumont stage VI oocytes. Oocytes were treated with collagenase type II (Sigma, 0.5 mg ml−1), defolliculated and incubated at 19 °C for 1-3 days prior to use. Electrophysiology Giant patch recordings (Baukrowitz et al. 1999) in the inside-out configuration under voltage-clamp conditions were made at room temperature (approximately 23 °C) 3-7 days after cRNA injection. Polylysine (Mr 30 000-70 000), diadenosine tetraphosphate (Ap4A), ATP, ADP and CoA were purchased from Sigma and TNP-AMP from Molecular Probes. Pipettes were made from thick-walled borosilicate glass, had resistances of 0.2-0.4 MΩ (tip diameter of 20-30 μm) and were filled with (mM): 120 KCl, 10 Hepes and 1.8 CaCl2 (pH adjusted to 7.2 with KOH). Currents were recorded with an EPC9 amplifier (HEKA Electronics, Lamprecht, Germany) and sampled at 1 kHz with the analog filter set to 3 kHz (-3 dB). Solutions were applied to the cytoplasmic side of excised patches via a multi-barrel pipette and had the following composition (mM): 120 KCl, 10 Hepes and 2 K2EGTA (Kint solution). Computational work was performed on a Macintosh G4 using commercial software (IGOR, WaveMetrics) and Excel 2001 (Microsoft). Preparation of lipid solutions L-α-Phosphatidyl-D-myo-inositol-4,5-bisphosphate (PIP2, from bovine brain) and oleoyl-CoA were purchased from Sigma, stored as stocks (1 mM) at -20 °C, diluted in Kint solution to final concentrations, sonicated for 15 min and used within 6 h. Initial experiments with oleoyl-CoA produced variable effects on the ATP sensitivity of KATP channels. This variability was most probably due to the absorption of oleoyl-CoA by the polyethylene tubing of our application system. If an oleoyl-CoA-containing solution remained for more than 15 min in the tubing then only small effects on KATP channels were observed. However, if the oleoyl-CoA solution was continuously flowing then oleoyl-CoA produced reproducible effects on KATP channels. For PIP2-containing solutions this effect was not observed. RESULTS Oleoyl-CoA reduced the ATP sensitivity of pancreatic and cardiac KATP channels with similar potency Figure 1
Further, PIP2 is known to reduce the sensitivity of KATP channels to sulphonylureas such as glibenclamide that inhibit KATP channels via the SUR (Koster et al. 1999; Krauter et al. 2001). Figure 1E R54Q and R176A reduced the modulation of ATP sensitivity by oleoyl-CoA The residues R54 and R176 in Kir6.2 are likely to interact with PIP2 directly (Huang et al. 1998; Soom et al. 2001; Schulze et al. 2003). Further, the mutations R176A and, especially, R54Q have been shown to markedly reduce the effect of PIP2 on ATP inhibition (Baukrowitz et al. 1998; Shyng & Nichols, 1998; Schulze et al. 2003). We therefore tested whether these mutations also interfered with the effect of oleoyl-CoA on the ATP sensitivity. The activity of R176A (and R54Q) channels declined spontaneously upon patch excision, and application of oleoyl-CoA dramatically increased the channel activity (Fig. 2A
Oleoyl-CoA affects KATP channels by an electrostatic mechanism A defining property for the effects of PIPs on KATP channels is their sensitivity to polyvalent cations such as polylysine and Mg2+, which reverse these effects (Fan & Makielski, 1997; Shyng & Nichols, 1998; Krauter et al. 2001). The effect of polylysine on the modulation of ATP sensitivity by oleoyl-CoA is shown in Fig. 3A
Effects of oleoyl-CoA and PIP2 on the inhibition of KATP channels by various (di)adenosine phosphates In addition to ATP, KATP channels are also sensitive to inhibition by ADP, AMP (Tucker et al. 1998) and diadenosine polyphosphates (ApnA) such as diadenosine tetraphosphate (Ap4A) (Jovanovic et al. 1996; Martin et al. 1998). ADP and AMP are thought to inhibit KATP channels via the same site and mechanism but with lower affinity than ATP (Tucker et al. 1998; Ribalet et al. 2003). However, inhibition by Ap4A has been suggested to be different from that by ATP (Martin et al. 1998). We compared the effects of oleoyl-CoA and PIP2 on the inhibition of KATP channels by the various (di)adenosine phosphates. Application of 75 μM TNP-AMP, 200 μM ADP, 15 μM ATP and 15 μM Ap4A inhibited between 40 and 60 % of the KATP current (Fig. 4C
CoA and Ap4A inhibit KATP channels via interaction with the ATP-binding site on Kir6.2 The CoA portion of the LC-CoA molecule is likely to interact with the KATP channel because it contains a highly negatively charged 3′-phosphorylated ADP group. Therefore, we tested whether CoA also activated KATP channels. Surprisingly, CoA caused a fast, reversible and dose-dependent inhibition of KATP channel activity with a Ki(CoA) of 265 ± 33 μM (Fig. 5A
We showed that Ap4A and ATP inhibition were similarly affected by oleoyl-CoA and PIP2 (Fig. 4A and B
DISCUSSION Here we show that the effects of oleoyl-CoA and PIP2 on KATP channels are virtually indistinguishable in all respects tested: (i) oleoyl-CoA and PIP2 reduced the ATP sensitivity of cardiac and pancreatic KATP channels with similar potency, (ii) both lipids abolished the inhibition by various other (di)adenosine phosphates (Ap4A, ADP, AMP) and the sulphonylurea glibenclamide, (iii) the effects of the two lipids on KATP channels displayed similar sensitivities to polycations (polylysine, Mg2+), and (iv) the mutations R54Q and R176Q reduced the effects of oleoyl-CoA and PIP2 on ATP sensitivity to similar extents. From these results we conclude that LC-CoA esters and PIPs modulate KATP channels via the same mechanism and interaction sites. This outcome fits nicely with a recent study by Rohacs et al. (2003) reporting that the PIP specificity of a Kir channel correlated with the ability to be activated by LC-CoA esters. Kir channels (Kir1.1, Kir2.1, Kir7.1) that discriminated between the different PIPs (e.g. PI(4,5)P2, PI(3,4)P2 and PI(3,4,5)P3) were not activated by LC-CoA esters. In contrast, KATP channels, which are not selective for the different PIPs, are potently activated by oleoyl-CoA. Rohacs et al. (2003) suggested that the low selectivity of the lipid interaction site on KATP channels allows the accommodation of PIPs as well as LC CoA esters. On the mechanism of oleoyl-CoA/PIP2 activation of KATP channels Our measurements with polyvalent cations (polylysine, Mg2+) indicate that oleoyl-CoA acts on KATP channels by an electrostatic mechanism as shown previously for PIP2. Even before the discovery of negative lipids as modulators of KATP channels, Deutsch and coworkers (1994) postulated the existence of a negative charge density on the KATP channel that controls ATP inhibition. In excised patches from cardiac myocytes these authors observed a large increase in ATP sensitivity in the presence of polyvalent cations such as Mg2+, Ca2+ and polylysine. Deutsch and coworkers (1994) suggested that these cations might screen a negative charge density located in the neighbourhood of the ATP-binding site that reduces the binding of ATP via electrostatic repulsion. The half-maximal effect of Mg2+ to increase ATP inhibition was observed at a concentration of about 2 mM (Deutsch et al. 1994). In good agreement, the half-maximal concentration for Mg2+ to abolish the effect of oleoyl-CoA or PIP2 on ATP inhibition was about 1.4 mM (Fig. 3D and F The results on the (di)adenosine phosphates argue against electrostatic interactions between ATP and oleoyl-CoA/PIP2 and, thus, are consistent with an allosteric mechanism where oleoyl-CoA/PIP2 reduces the sensitivity to ATP by increasing the open state stability (Enkvetchakul et al. 2000). However, the results are also consistent with a mechanism where oleoyl-CoA/PIP2 and the adenosine phosphates bind in a mutually exclusive manner to an overlapping site on the channel (Fan & Makielski, 1999; MacGregor et al. 2002), because this would also predict no difference for the effect of oleoyl-CoA/PIP2 on the various (di)adenosine phosphates as observed. Therefore, our results cannot distinguish between these two scenarios but rule out a mechanism where oleoyl-CoA/PIP2 and ATP bind to neighbouring sites that are close enough to allow electrostatic cross-talk. CoA and (di)adenosine polyphosphates are ligands of the ATP-binding site onKir6.2 To our surprise, we found that CoA, in contrast to oleoyl-CoA, inhibited KATP channels. This inhibition was abolished by oleoyl-CoA and PIP2 and reduced by mutations (R50E, K185Q) of residues that are thought to be involved in the binding of the adenosine phosphates (ATP, ADP, AMP) (Tucker et al. 1998; Ribalet et al. 2003). Further, ATP reduced the apparent sensitivity of KATP channels to inhibition by CoA as though the two molecules directly competed for inhibition. These results suggest that ATP and CoA bind to the same site. Intriguingly, CoA contains a 3′-phosphorylated ADP group that is likely to mediate the interaction with the ATP (adenosine phosphate)-binding site. However, because of its negative charge, the 3′-phosphorylated ADP group is also likely to mediate the interaction with the lipid-binding site. As stated previously (Shyng et al. 2000; Cukras et al. 2002; Schulze et al. 2003), the sites are most probably not identical since the sensitivity to oleoyl-CoA/PIP2 and CoA/ATP is affected by different sets of mutations (e.g. Fig. 2 While screening for mechanistic differences between oleoyl-CoA and PIP2, we used diadenosine tetraphosphate (Ap4A), which is a potent inhibitor of cardiac (Jovanovic et al. 1996) and pancreatic KATP channels (Martin et al. 1998). It has been proposed that Ap4A and ATP inhibit KATP channels by different mechanisms (Martin et al. 1998). However, our results strongly suggest that Ap4A and ATP interact with the same site on Kir6.2. Similar to ATP, oleoyl-CoA/PIP2 and R50E/K185Q reduced the inhibition of KATP channels by Ap4A. Moreover, we showed competition between Ap4A and ATP for the inhibition of KATP channels. These results question the physiological relevance of ApnA as regulators of KATP channels. ApnA have been proposed to be involved in glucose-dependent insulin secretion in pancreatic β cells because ApnA concentrations rise upon glucose stimulation and inhibition of KATP channel activity is known to trigger insulin secretion. However, the intracellular concentrations of ATP in β cells are in the range 3-5 mM (Niki et al. 1989). Thus, given the observed competition between ATP and Ap4A (Fig. 6C and D Acknowledgments The authors appreciate the excellent technical support by Dr Hariolf Fritzenschaft, and thank Dr Klaus Benndorf and Dr Christoph Biskup for critically reading the manuscript. This work was supported by grant Ba 1793 from the Deutsche Forschungsgemeinschaft (to T.B.). REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Annu Rev Physiol. 1997; 59():171-91.
[Annu Rev Physiol. 1997]J Biol Chem. 1998 Nov 20; 273(47):31395-400.
[J Biol Chem. 1998]J Biol Chem. 1998 Oct 9; 273(41):26383-7.
[J Biol Chem. 1998]Circ Res. 2001 May 11; 88(9):918-24.
[Circ Res. 2001]J Biol Chem. 1997 Feb 28; 272(9):5388-95.
[J Biol Chem. 1997]J Gen Physiol. 2002 Sep; 120(3):437-46.
[J Gen Physiol. 2002]J Biol Chem. 2003 Mar 21; 278(12):10500-5.
[J Biol Chem. 2003]J Biol Chem. 1997 Feb 28; 272(9):5388-95.
[J Biol Chem. 1997]J Gen Physiol. 2000 Nov; 116(5):599-608.
[J Gen Physiol. 2000]Science. 1998 Nov 6; 282(5391):1141-4.
[Science. 1998]Biophys J. 2000 May; 78(5):2334-48.
[Biophys J. 2000]J Gen Physiol. 1999 Aug; 114(2):251-69.
[J Gen Physiol. 1999]Proc Natl Acad Sci U S A. 2002 Mar 5; 99(5):2726-31.
[Proc Natl Acad Sci U S A. 2002]J Gen Physiol. 1994 Oct; 104(4):773-800.
[J Gen Physiol. 1994]Circ Res. 2001 May 11; 88(9):918-24.
[Circ Res. 2001]J Biol Chem. 1998 Oct 9; 273(41):26383-7.
[J Biol Chem. 1998]EMBO J. 1999 Feb 15; 18(4):847-53.
[EMBO J. 1999]Cell. 1995 Jan 13; 80(1):149-54.
[Cell. 1995]EMBO J. 1999 Feb 15; 18(4):847-53.
[EMBO J. 1999]J Biol Chem. 1998 Oct 9; 273(41):26383-7.
[J Biol Chem. 1998]J Gen Physiol. 1999 Aug; 114(2):203-13.
[J Gen Physiol. 1999]Mol Pharmacol. 2001 May; 59(5):1086-93.
[Mol Pharmacol. 2001]Nature. 1998 Feb 19; 391(6669):803-6.
[Nature. 1998]FEBS Lett. 2001 Feb 9; 490(1-2):49-53.
[FEBS Lett. 2001]J Biol Chem. 2003 Mar 21; 278(12):10500-5.
[J Biol Chem. 2003]Science. 1998 Nov 6; 282(5391):1141-4.
[Science. 1998]Science. 1998 Nov 6; 282(5391):1138-41.
[Science. 1998]J Biol Chem. 1997 Feb 28; 272(9):5388-95.
[J Biol Chem. 1997]Science. 1998 Nov 6; 282(5391):1138-41.
[Science. 1998]Mol Pharmacol. 2001 May; 59(5):1086-93.
[Mol Pharmacol. 2001]EMBO J. 1998 Jun 15; 17(12):3290-6.
[EMBO J. 1998]Pflugers Arch. 1996 Mar; 431(5):800-2.
[Pflugers Arch. 1996]FASEB J. 1998 Nov; 12(14):1499-506.
[FASEB J. 1998]Biophys J. 2003 Jan; 84(1):266-76.
[Biophys J. 2003]J Biol Chem. 2003 Mar 21; 278(12):10500-5.
[J Biol Chem. 2003]EMBO J. 1998 Jun 15; 17(12):3290-6.
[EMBO J. 1998]Proc Natl Acad Sci U S A. 2003 Jan 21; 100(2):745-50.
[Proc Natl Acad Sci U S A. 2003]J Gen Physiol. 1994 Oct; 104(4):773-800.
[J Gen Physiol. 1994]Biophys J. 2000 May; 78(5):2334-48.
[Biophys J. 2000]J Gen Physiol. 1999 Aug; 114(2):251-69.
[J Gen Physiol. 1999]Proc Natl Acad Sci U S A. 2002 Mar 5; 99(5):2726-31.
[Proc Natl Acad Sci U S A. 2002]EMBO J. 1998 Jun 15; 17(12):3290-6.
[EMBO J. 1998]Biophys J. 2003 Jan; 84(1):266-76.
[Biophys J. 2003]J Gen Physiol. 2000 Nov; 116(5):599-608.
[J Gen Physiol. 2000]J Gen Physiol. 2002 Sep; 120(3):437-46.
[J Gen Physiol. 2002]J Biol Chem. 2003 Mar 21; 278(12):10500-5.
[J Biol Chem. 2003]Pflugers Arch. 1996 Mar; 431(5):800-2.
[Pflugers Arch. 1996]FASEB J. 1998 Nov; 12(14):1499-506.
[FASEB J. 1998]FEBS Lett. 1989 Nov 6; 257(2):361-4.
[FEBS Lett. 1989]